Simulations Plus’ (SLP) “Outperform” Rating Reaffirmed at William Blair

William Blair reiterated their outperform rating on shares of Simulations Plus (NASDAQ:SLP) in a research note issued to investors on Wednesday,RTT News reports.

Several other equities research analysts have also recently issued reports on SLP. BTIG Research decreased their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. Stephens assumed coverage on shares of Simulations Plus in a research report on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. Finally, StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $49.00.

Simulations Plus Trading Down 7.2 %

NASDAQ:SLP opened at $28.21 on Wednesday. The firm has a 50-day moving average price of $29.79 and a two-hundred day moving average price of $34.00. Simulations Plus has a twelve month low of $24.00 and a twelve month high of $51.22. The company has a market capitalization of $566.60 million, a P/E ratio of 57.57 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The business had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.18 earnings per share. On average, equities research analysts predict that Simulations Plus will post 1.1 earnings per share for the current year.

Insider Buying and Selling at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $27.66, for a total transaction of $553,200.00. Following the transaction, the director now directly owns 3,462,584 shares of the company’s stock, valued at approximately $95,775,073.44. The trade was a 0.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 19.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in SLP. Tributary Capital Management LLC lifted its position in shares of Simulations Plus by 54.7% during the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after purchasing an additional 115,122 shares in the last quarter. Royce & Associates LP lifted its position in shares of Simulations Plus by 28.8% during the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock worth $7,602,000 after purchasing an additional 53,092 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after purchasing an additional 37,992 shares in the last quarter. Congress Asset Management Co. lifted its position in shares of Simulations Plus by 22.5% during the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock worth $6,613,000 after purchasing an additional 37,914 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in shares of Simulations Plus by 402.9% during the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock worth $1,279,000 after purchasing an additional 32,002 shares in the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.